Beijing Northland Biotech Co (BJSE:920047) Construction In Progress: ¥201.34 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920047 Beijing Northland Biotech Co Ltd BJSE:920047
59 GF Score
Price ¥15.57
GF Value ¥15.45
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Beijing Northland Biotech Co Construction In Progress?

Beijing Northland Biotech Co BJSE:920047 59 Construction In Progress is ¥201.34 Mil as of Jun. 2026. GuruFocus rates BJSE:920047 with a GF Score™ of 59/100 and a GF Value™ of ¥15.45 (Fairly Valued). The stock has 7 warning signs investors should review.

Beijing Northland Biotech Co's quarterly construction in progress increased from Dec. 2025 (¥170.78 Mil) to Mar. 2026 (¥172.17 Mil) and increased from Mar. 2026 (¥172.17 Mil) to Jun. 2026 (¥201.34 Mil).

Beijing Northland Biotech Co's annual construction in progress increased from Dec. 2023 (¥114.80 Mil) to Dec. 2024 (¥124.10 Mil) and increased from Dec. 2024 (¥124.10 Mil) to Dec. 2025 (¥170.78 Mil).

Beijing Northland Biotech Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Beijing Northland Biotech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Northland Biotech Co Construction In Progress Chart

Beijing Northland Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.03 49.87 114.80 124.10 170.78

Beijing Northland Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.23 134.03 170.78 172.17 201.34
BJSE:920047
59GF Score
Beijing Northland Biotech Co Ltd BJSE:920047
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Northland Biotech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥201.34 Mil mean?
Beijing Northland Biotech Co (BJSE:920047) has a Construction In Progress of ¥201.34 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Beijing Northland Biotech Co and its competitors.
Is Beijing Northland Biotech Co's Construction In Progress too high?
Beijing Northland Biotech Co's current Construction In Progress is ¥201.34 Mil. Overall, Beijing Northland Biotech Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Northland Biotech Co's Construction In Progress compare to VRTX and REGN?
Beijing Northland Biotech Co's Construction In Progress of ¥201.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Beijing Northland Biotech Co and its competitors. Beijing Northland Biotech Co's current Construction In Progress is ¥201.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Northland Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Northland Biotech Co (BJSE:920047) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.45, compared to a current price of ¥15.57 — trading 0.8% above its estimated fair value. The current Construction In Progress is ¥201.34 Mil. Beijing Northland Biotech Co's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Beijing Northland Biotech Co (BJSE:920047), the current Construction In Progress is ¥201.34 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Northland Biotech Co (BJSE:920047) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Northland Biotech Co stock appears to be overvalued. The current stock price of ¥15.57 is trading 0.8% above its estimated GF Value™ of ¥15.45. GuruFocus considers Beijing Northland Biotech Co to be Fairly Valued.

Key valuation signals for BJSE:920047:

  • Construction In Progress: ¥201.34 Mil
  • GF Value™: ¥15.45 vs. price of ¥15.57 (0.8% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920047 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Northland Biotech Co Business Description

Address No. 5 Shangdi Kaituo Road, Room A406, Zhongguancun Biomedicine Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is engaged in technology transfer, technical services, production and sales of ophthalmic drugs, contract manufacturing, and contract research and development. The company's independently developed biopharmaceutical, NL003, has completed Phase III clinical trials this year.
59GF Score

Get the complete analysis for BJSE:920047

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.57
Price
¥15.45
GF Value